Nationally representative surveys on cannabis use lack product details relevant to public health.

ABSTRACT:

Objectives

Many annual, nationally representative US surveys that assess cannabis use do not collect information on product characteristics despite varying health risks and benefits. Capitalizing on a rich dataset of primarily medical users, the purpose of this study was to describe the degree of potential misclassification in clinically relevant cannabis use measures when primary mode of use is recorded but not product type.

Methods

Analyses consider user-level data from the Releaf App™ database on product types, consumption modes, and potencies in a non-nationally representative sample of 26,322 cannabis administration sessions occurring in 2018, across 3,258 users. Proportions, means, and 95% confidence intervals were calculated and compared across products and modes.

SUBMITTER: Stith S 

PROVIDER: S-EPMC10040319 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature